/third-meeting-of-the-intergovernmental-working-group-on-the-who-pandemic-agreement.tmb-1200v.jpg?sfvrsn=b400bf69_6)
Geneva – Global health leaders are signaling cautious optimism as countries continue negotiations on a crucial annex to the landmark WHO Pandemic Agreement. The agreement, adopted in May 2025, aims to strengthen international cooperation in preventing, preparing for, and responding to future pandemics, lessons learned from the inequities and gaps exposed during the COVID-19 crisis. Currently, focus is on the Pathogen Access and Benefit-Sharing (PABS) system, a component designed to ensure equitable access to vital resources during health emergencies.
The fifth meeting of the Intergovernmental Working Group on the WHO Pandemic Agreement (IGWG) concluded over the weekend, February 14, 2026, after a week of discussions. Negotiations centered on establishing a framework for the rapid sharing of pathogen materials and genetic sequence data – essential for accelerating the development of diagnostics, treatments, and vaccines – alongside a system for fairly distributing the benefits that arise from these innovations. The core principle underpinning the PABS system is equitable access based on public health need, a concept repeatedly emphasized by the World Health Organization (WHO) and member states.
A Framework for Equitable Access
The need for a robust PABS system stems from the challenges experienced during the COVID-19 pandemic, where access to vaccines, therapeutics, and diagnostic tools was unevenly distributed globally. The WHO Pandemic Agreement, a legally binding international instrument, seeks to correct these weaknesses and foster a more collaborative and equitable approach to pandemic preparedness and response. The agreement represents a historic moment for global public health, according to the WHO.
“Countries this week have again shown their steadfast commitment to getting the Pathogen Access and Benefit Sharing annex done,” said Ambassador Tovar da Silva Nunes, of Brazil, and co-chair of the IGWG Bureau. “We now have a clear vision for streamlining the text, while ensuring that the more contentious elements receive the necessary consultation.” This suggests that while progress is being made, significant hurdles remain in reaching a consensus on all aspects of the PABS system.
Navigating Contentious Issues
While the overall goal of equitable access is widely supported, the specifics of how to achieve it – particularly regarding intellectual property rights, benefit-sharing mechanisms, and the timely transfer of technology – are proving to be complex. Negotiations are focused on balancing the need to incentivize innovation with the imperative of ensuring that essential medical tools are available to all countries, regardless of their economic status. The ongoing negotiations reflect a global commitment to addressing these challenges.
Stakeholder Engagement
The IGWG’s work isn’t happening in a vacuum. Alongside governmental discussions, member states have been actively engaging with a diverse range of stakeholders, including representatives from the private sector, academic institutions, laboratories, and sequence information databases. This inclusive approach aims to ensure that the PABS system is practical, effective, and reflects the perspectives of all relevant actors. The involvement of these groups is seen as crucial for building trust and fostering a collaborative environment.
Looking Ahead: May Deadline Looms
With the May deadline for presenting the outcome of the PABS negotiations to the World Health Assembly rapidly approaching, the coming weeks are critical. Mr. Matthew Harpur, of the United Kingdom and co-chair of the IGWG Bureau, emphasized the urgency, stating, “With time running short, the coming weeks will be critical in bridging the remaining gaps and delivering a Pathogen Access and Benefit Sharing annex that is fair, effective, and fit for purpose.”
WHO Director-General Dr. Tedros Adhanom Ghebreyesus expressed confidence that an agreement can be reached in time for the May assembly, highlighting the importance of continued multilateralism. “Adopting the Pandemic Agreement last year was a huge testament to global cooperation, and we need to build on that momentum,” he said. “Strong multilateralism remains essential as countries have to face future pandemics together, collectively.”
The successful implementation of the WHO Pandemic Agreement, and specifically the PABS system, represents a significant step towards a more prepared and equitable world in the face of future health threats. The next meeting of the IGWG is scheduled for next month, and the outcome will be closely watched by the global health community. Updates on the negotiations and the final agreement will be available on the WHO website.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or legal advice. It is essential to consult with qualified professionals for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the ongoing negotiations for the Pandemic Agreement? Share your comments below, and please share this article with your network.
